ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2026

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

A Carugno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.